215 related articles for article (PubMed ID: 26606199)
1. Regulators of Glucose Metabolism in CD4
Palmer CS; Hussain T; Duette G; Weller TJ; Ostrowski M; Sada-Ovalle I; Crowe SM
Int Rev Immunol; 2016 Nov; 35(6):477-488. PubMed ID: 26606199
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB.
Finlay DK
Biochem Soc Trans; 2013 Apr; 41(2):681-6. PubMed ID: 23514176
[TBL] [Abstract][Full Text] [Related]
3. Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection.
Palmer CS; Duette GA; Wagner MCE; Henstridge DC; Saleh S; Pereira C; Zhou J; Simar D; Lewin SR; Ostrowski M; McCune JM; Crowe SM
FEBS Lett; 2017 Oct; 591(20):3319-3332. PubMed ID: 28892135
[TBL] [Abstract][Full Text] [Related]
4. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
Finlay DK; Rosenzweig E; Sinclair LV; Feijoo-Carnero C; Hukelmann JL; Rolf J; Panteleyev AA; Okkenhaug K; Cantrell DA
J Exp Med; 2012 Dec; 209(13):2441-53. PubMed ID: 23183047
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis.
Liu X; Yamaguchi K; Takane K; Zhu C; Hirata M; Hikiba Y; Maeda S; Furukawa Y; Ikenoue T
PLoS One; 2021; 16(9):e0257090. PubMed ID: 34516556
[TBL] [Abstract][Full Text] [Related]
6. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
7. Foxp3 and Toll-like receptor signaling balance T
Gerriets VA; Kishton RJ; Johnson MO; Cohen S; Siska PJ; Nichols AG; Warmoes MO; de Cubas AA; MacIver NJ; Locasale JW; Turka LA; Wells AD; Rathmell JC
Nat Immunol; 2016 Dec; 17(12):1459-1466. PubMed ID: 27695003
[TBL] [Abstract][Full Text] [Related]
8. TAPP Adaptors Control B Cell Metabolism by Modulating the Phosphatidylinositol 3-Kinase Signaling Pathway: A Novel Regulatory Circuit Preventing Autoimmunity.
Jayachandran N; Mejia EM; Sheikholeslami K; Sher AA; Hou S; Hatch GM; Marshall AJ
J Immunol; 2018 Jul; 201(2):406-416. PubMed ID: 29884706
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.
Siska PJ; van der Windt GJ; Kishton RJ; Cohen S; Eisner W; MacIver NJ; Kater AP; Weinberg JB; Rathmell JC
J Immunol; 2016 Sep; 197(6):2532-40. PubMed ID: 27511728
[TBL] [Abstract][Full Text] [Related]
10. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
11. IL-33 activates mTORC1 and modulates glycolytic metabolism in CD8
Liang Y; Wang X; Wang H; Yang W; Yi P; Soong L; Cong Y; Cai J; Fan X; Sun J
Immunology; 2022 Jan; 165(1):61-73. PubMed ID: 34411293
[TBL] [Abstract][Full Text] [Related]
12. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
13. Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions.
Cretenet G; Clerc I; Matias M; Loisel S; Craveiro M; Oburoglu L; Kinet S; Mongellaz C; Dardalhon V; Taylor N
Sci Rep; 2016 Apr; 6():24129. PubMed ID: 27067254
[TBL] [Abstract][Full Text] [Related]
14. Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy.
Masson JJR; Murphy AJ; Lee MKS; Ostrowski M; Crowe SM; Palmer CS
PLoS One; 2017; 12(8):e0183931. PubMed ID: 28854263
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
16. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
17. Early changes in the metabolic profile of activated CD8(+) T cells.
Cammann C; Rath A; Reichl U; Lingel H; Brunner-Weinzierl M; Simeoni L; Schraven B; Lindquist JA
BMC Cell Biol; 2016 Jul; 17(1):28. PubMed ID: 27387758
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells.
Cao Y; Rathmell JC; Macintyre AN
PLoS One; 2014; 9(8):e104104. PubMed ID: 25090630
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
Hong SY; Yu FX; Luo Y; Hagen T
Cell Signal; 2016 May; 28(5):377-383. PubMed ID: 26826652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
